Squarepoint Ops LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,742,901

+$2,201,829 QoQ

Shares Held

178,915

+2.9% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. TNGX ranks #49 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,742,901	178,915	+2.9%	Shares	Defined	2026-05-15
2025-12-31	$1,541,072	173,936	+1254.3%	Shares	Defined	2026-02-13
2024-12-31	$39,684	12,843	-9.3%	Shares	Defined	2025-02-14
2024-06-30	$121,475	14,158	-78.3%	Shares	Defined	2024-08-14
2024-03-31	$517,672	65,198	-34.7%	Shares	Defined	2024-05-15
2023-12-31	$988,099	99,808	+147.6%	Shares	Defined	2024-02-14
2023-06-30	$133,849	40,316	-56.5%	Shares	Defined	2023-08-14
2023-03-31	$366,315	92,738	+231.5%	Shares	Defined	2023-05-15
2022-09-30	$101,283	27,979	-66.5%	Shares	Defined	2022-11-14
2022-03-31	$633,346	83,555	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.